434 related articles for article (PubMed ID: 18195148)
1. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.
Fotenos AF; Mintun MA; Snyder AZ; Morris JC; Buckner RL
Arch Neurol; 2008 Jan; 65(1):113-20. PubMed ID: 18195148
[TBL] [Abstract][Full Text] [Related]
2. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.
Fotenos AF; Snyder AZ; Girton LE; Morris JC; Buckner RL
Neurology; 2005 Mar; 64(6):1032-9. PubMed ID: 15781822
[TBL] [Abstract][Full Text] [Related]
3. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
Morris JC; Roe CM; Grant EA; Head D; Storandt M; Goate AM; Fagan AM; Holtzman DM; Mintun MA
Arch Neurol; 2009 Dec; 66(12):1469-75. PubMed ID: 20008650
[TBL] [Abstract][Full Text] [Related]
4. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
[TBL] [Abstract][Full Text] [Related]
6. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
7. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
[TBL] [Abstract][Full Text] [Related]
8. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
9. A test of lens opacity as an indicator of preclinical Alzheimer Disease.
Bei L; Shui YB; Bai F; Nelson SK; Van Stavern GP; Beebe DC
Exp Eye Res; 2015 Nov; 140():117-123. PubMed ID: 25773986
[TBL] [Abstract][Full Text] [Related]
10. Association of gray matter atrophy with age, β-amyloid, and cognition in aging.
Oh H; Madison C; Villeneuve S; Markley C; Jagust WJ
Cereb Cortex; 2014 Jun; 24(6):1609-18. PubMed ID: 23389995
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
[TBL] [Abstract][Full Text] [Related]
12. Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging.
Wang L; Swank JS; Glick IE; Gado MH; Miller MI; Morris JC; Csernansky JG
Neuroimage; 2003 Oct; 20(2):667-82. PubMed ID: 14568443
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of the transition from healthy aging to Alzheimer disease.
Johnson DK; Storandt M; Morris JC; Galvin JE
Arch Neurol; 2009 Oct; 66(10):1254-9. PubMed ID: 19822781
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
[TBL] [Abstract][Full Text] [Related]
15. Peripheral insulin and brain structure in early Alzheimer disease.
Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
[TBL] [Abstract][Full Text] [Related]
17. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
Haroutunian V; Perl DP; Purohit DP; Marin D; Khan K; Lantz M; Davis KL; Mohs RC
Arch Neurol; 1998 Sep; 55(9):1185-91. PubMed ID: 9740112
[TBL] [Abstract][Full Text] [Related]
18. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
19. Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease.
McDonough IM; Bischof GN; Kennedy KM; Rodrigue KM; Farrell ME; Park DC
Neurobiol Aging; 2016 Oct; 46():68-75. PubMed ID: 27460151
[TBL] [Abstract][Full Text] [Related]
20. "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis.
Masters MC; Morris JC; Roe CM
Neurology; 2015 Feb; 84(6):617-22. PubMed ID: 25589671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
